The venture capital subsidiary of a large healthcare corporation based in Europe invests to take minority stakes in innovative technology start-ups. The firm can lead or co-invest with other investors. Typical allocations are made in equity and range from €1-10 million. The firm is currently seeking new opportunities across a wide geography, including Western Europe, North and South America and Asia.
The firm focuses on medical devices and health IT products that present novel treatment, monitoring, or self-care strategies in home settings. In general, the firm is interested in chronic diseases, particularly in COPD, sleep apnea, renal diseases, and Parkinson’s disease. The technology should complement its current portfolio and fit the parent group’s long-term goals. The firm specializes in early stage projects from concept to clinical development.
The firm is looking for competent management teams with some previous experience in taking a company to an exit and understanding of the negotiations throughout the process. The firm typically takes a board seat in the companies it invests in.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a Reply